| Oral presentation schedule for November 4 (Fri), Day 2 |
| |
|
Kobe International Exhibition Hall No.2 Building |
Portopia Hotel |
Kobe International Conference Center |
Kobe International Exhibition Hall No.1 Building |
Kobe International Exhibition Hall No.2 Building |
|
| |
|
Hall (South) |
Conference Room 3A |
Portopia Hall |
Ohwada A |
Ohwada B |
Ohwada C |
Kairaku 1 |
Kairaku 2 |
Kairaku 3 |
Waraku |
Topaz |
Emerald |
Ikuta |
501+502 |
Digital Poster Session & Commercial Exhibition |
Digital Poster Session & Commercial Exhibition |
|
| |
|
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
Room 8 |
Room 9 |
Room 10 |
Room 11 |
Room 12 |
Room 13 |
Room 14 |
Room 15 |
Room 16 |
|
| 8:00 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 |
| 45 |
|
No planned seminars |
Breakfast
Seminar8 Century Medical,Inc.
Not too late, Starting colonic stenting! -Aiming stoma free- |
No planned seminars |
Breakfast
Seminar9 Hitachi, Ltd.
Cutting edge of endoscopic biliary drainage |
Breakfast
Seminar10 NIPPONKAYAKU CO., LTD.
Treatment strategy of IBD using biologics –Clinical experience with infliximab biosimilar– |
Breakfast
Seminar11 GADELIUS MEDICAL K.K.
Plastic stent innovation part3 |
Breakfast
Seminar12 Kyorin Pharmaceutical Company, Limited
An update on the mode of action of 5-ASA in ulcerative colitis |
Breakfast
Seminar13 Otsuka Pharmaceutical Co., Ltd. / Takeda Pharmaceutical Company Limited
Light and shadow in antithrombotic therapy |
Breakfast
Seminar14 Yakult Honsha Co., Ltd.
The front-line of gastric cancer chemotherapy for surgeons |
Breakfast
Seminar15 MIYARISAN PHARMACEUTICAL CO., LTD.
Application of intestinal microbiota for development of novel treatment |
Breakfast
Seminar16 Eisai Co., Ltd. / EIDIA Co., Ltd
Update of HCC treatment |
Breakfast
Seminar17 Alfresa pharma corporation
Novel strategy for IBD treatment using fecal biomarkes |
Breakfast
Seminar18 EA Pharma Co., Ltd.
BCAA & Exercise Therapy for Hepatoma Patients |
|
|
|
45 |
| 9:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
9:00 |
| 30 |
|
S2 (JSGS)
Laparoscopic gastrectomy <Video> Chair: K. Yoshida
E. Otsuji |
S3 (JSGS / JSGE / JGES)
Treatment strategy for rectal cancer Chair: M. Watanabe
K. Maeda |
PD8 (JSGE / JGES / JSGS)
Therapeutic strategy for biologics-resistant inflammatory bowel disease Chair: A. Andoh
R. Hokari |
W10 (JSGE / JGES / JSGS / JSGCS)
Issues and solutions in the management of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas Chair: M. Kon
K. Shimizu |
Integrated Program 3(S) (JDDW (JSGE / JGES / JSGS))
Clinical issues in cancer of the esophagogastric junction Chair: M. Ichinose
Y. Doki
T. Oyama |
Invited Lecture (JSH)
Treatment strategy for hepatocellular carcinoma and future perspective V. Mazzaferro
Chair: T. Takayama |
W11 (JGES / JSGE / JSGS / JSGCS)
Cutting edge of endoscopic diagnosis and treatment for superficial cancer in hypopharynx and cervical esophagus Chair: T. Omori
M. Arima |
IS-S2 (JSGE / JSH)
Roles of microbiota for nervous, metabolic, and immune systems Chair: M. E. Gershwin
T. Kanai |
W13 (JSGS / JSGE)
New surgical approaches for advanced biliary cancer Chair: M. Nagino
I. Endo |
W14 (JSGS / JSGE / JSH)
3D simulation of the anatomy in the gastrointestinal and hepato-biliary pancreatic surgery Chair: S. Kawasaki
K. Yanaga |
W15 (JSH / JSGE)
Best treatment strategy for portal hypertension Chair: S. Kokubu
A. Nakajima |
Live broadcast
Room |
Live broadcast
Room |
JDDW 2016 Hands-on seminar 1 (ESD) Coordinator:
Y. Morita |
|
|
Commercial Exhibition |
|
|
Commercial Exhibition |
30 |
| 40 |
| Digital Poster Session (JSGS) |
9:30 | 11:30 |
| Digital Poster Session (JSGS) |
9:30 | 11:30 |
| International Poster Session |
9:30 | 11:30 |
40 |
| 10:00 |
PD10 (JSH / JSGE / JSGS)
Best timing and limitation of surgical treatment for HCC Chair: N. Kokudo
M. Shimada |
10:00 |
| 11:00 |
|
|
|
11:00 |
| 20 |
|
|
|
20 |
| 30 |
Special Lecture (JSGE)
How to train young gastroenterologists with broad knowledge of internal medicine T. Chiba
Chair: K. Sugano |
Invited Lecture (JGES)
Update therapeutic approach to the upper GI diseases - focus on GERD P. Malfertheiner
Chair: M. Kaise |
30 |
| 12:00 |
|
|
|
12:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 13:00 |
Luncheon
Seminar40 MSD K.K.
New Treatment Option For Chronic Hepatitis C -Current Issue and Recent Evidence- |
Luncheon
Seminar41 ONO PHARMACEUTICAL CO., LTD. / Bristol-Myers Squibb K.K.
Recent advances and future perspective of cancer immunotherapy |
No planned seminars |
Luncheon
Seminar42 JIMRO Co., Ltd.
Tips of GMA Therapy in Ulcerative Colitis |
Luncheon
Seminar43 ZEON MEDICAL INC.
History and Progress of the Biliary and Pancreatic Endoscopic Treatment |
Luncheon
Seminar44 Otsuka Pharmaceutical Co., Ltd.
Managements of Symptoms in Liver Cirrhosis
- Sarcopenia and Hepatic Encephalopathy - & OTSUKA Award 2016 |
Luncheon
Seminar45 EA Pharma Co, Ltd.
Consideration of acid secretion inhibitor in Japan |
Luncheon
Seminar46 SHIONOGI & CO., LTD.
Symptom management in patients with gastroenterological cancer |
Luncheon
Seminar47 Eli Lilly Japan K.K.
Chemotherapy of gastrointestinal cancer |
Luncheon
Seminar48 CHUGAI PHARMACEUTICAL CO., LTD
Current treatment strategy for metastatic colorectal cancer |
Representative Conference (Japanese Society of Gastrointestinal Cancer Screening)
12:30-13:30 |
Luncheon
Seminar49 Takeda Pharmaceutical Company Limited Medical Affairs-Japan
Role of the adhesion molecule on the inflammatory bowel disease |
Luncheon
Seminar50 Johnson & Johnson K. K. Medical Company
The Latest Laparoscopic Hepatectomy |
13:00 |
| 30 |
|
|
|
|
30 |
| 40 |
|
40 |
| 14:00 |
|
|
|
|
|
|
|
|
|
|
|
|
14:00 |
| 40 |
|
PD7 (JGES / JSGE / JSGS / JSGCS)
Benefits and harms of ESD in the era of its bloom Chair: H. Yamamoto
H. Ono |
W9 (JSH / JSGE / JSGS)
Update of hepatitis B treatment Chair: E. Tanaka
H. Okamoto |
Lecture by Congress President (JSGS)
Where there is a will, there is a way - Yes, We Can W. Kimura
Chair: Y. Atomi |
PD9 (JSGE / JGES / JSGS / JSGCS)
Long-term clinical course of Japanese patients with inflammatory bowel disease: What are current and optimal modalities for monitoring disease activity? Chair: T. Matsumoto
H. Nakase |
Integrated Program 4(S) (JDDW (JSGE / JSGS))
Problems and tasks in pancreatic cancer treatment Chair: H. Yamaue
J. Furuse |
Invited Lecture (JGES)
Education for GI endoscopists in Taiwan H.-P. Wang
Chair: S. Ryozawa |
W12 (JSH / JSGE / JSGS)
Best timing of targeting therapy for hepatocellular carcinoma Chair: M. Kudo
M. Omata |
IS-S3 (JSGS / JSGE)
Benefit and pitfall in laparoscopic surgery Chair: H.-S. Han
H. Kaneko |
S4 (JSGE / JSH)
Current state of regenerative medicine and stem cell research in digestive system Chair: M. Watanabe
T. Takehara |
Live broadcast
Room |
Live broadcast
Room |
Live broadcast
Room |
Women's Committee of Japanese Gastroenterology Study Group (JDDW)
The art of patients support by taking advantage of women doctors
-Learning from experts in various medical fields- Chair: H. Ishii
Y. Takahashi |
JDDW 2016 Hands-on seminar 2 (Colon insertion method) Coordinator:
T. Matsuda |
| Digital Poster Session (JSGE) |
14:00 | 16:30 |
| Digital Poster Session (JSGS) |
14:00 | 16:30 |
| Digital Poster Session (JGES) |
14:00 | 16:30 |
| Digital Poster Session (JSH) |
14:00 | 16:30 |
| International Poster Session |
14:00 | 16:30 |
40 |
| 15:00 |
Special Lecture (JSGS)
The story of researches over the Nobel Prize Y. Morioka
Chair: T. Muto |
JGES Featured Session <Panel Discussion> (JGES)
Interventional EUS: Its indications and limitations Chair: S. Ryozawa
N. Fujita |
15:00 |
| 20 |
|
20 |
| 16:00 |
Invited Lecture (JSGS)
Pancreatology 2016: What is new? J. Mossner
Chair: H. Nagai |
16:00 |
| 30 |
|
Invited Lecture (JSGS)
Parenchyma-sparing, local duodenum-preserving pancreatic head resection for cystic neoplasms, neuroendocrine adenoma and low-risk periampullary cancer H. G. Beger
Chair: M. Makuuchi |
30 |
| 40 |
|
|
|
40 |
| 17:00 |
|
17:00 |
| 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
| 30 |
Japan Gastroenterological Endoscopy Society Awards Ceremony |
30 |
| 18:00 |
Incorporated Association Council and Academic Council (Japan Gastroenterological Endoscopy Society)
17:30-18:45 |
Satellite
Symposium72 Bristol-Myers Squibb K.K.
Trajectory of Chronic Hepatitis B treatment |
Satellite
Symposium73 OLYMPUS CORPORATION
A Decade of NBI -The history and expansion to the world- |
Satellite
Symposium74 MOCHIDA PHARMACEUTICAL CO., LTD.
A new therapeutic strategy for ulcerative colitis |
Setting up the JDDW Banquet Room |
Satellite
Symposium75 Sumitomo Dainippon Pharma Co., Ltd
The Treatment of hepatocellular carcinoma using miriplatin |
Satellite
Symposium76 EA Pharma Co., Ltd.
Strategy of improving the prognosis for patients with liver cirrhosis -Efficacy of early nutrition support by BCAA for liver cirrhosis- |
Satellite
Symposium77 ASKA Pharmaceutical Co., Ltd.
Management for Hepatic cirrhosis |
Satellite
Symposium78 Otsuka Pharmaceutical Factory,Inc. / EN Otsuka Pharmaceutical Co., Ltd.
Up to date on the Medical Management of Crohn's Disease |
Satellite
Symposium79 Sysmex Corporation
Remaining Challenges for the Post-hepatitis-virus Era |
Satellite
Symposium80 Covidien Japan Inc.
–KIWAMERU (Master) – Our laparoscopic colon resection |
Satellite
Symposium81 TAIHO PHARMACEUTICAL CO., LTD.
Development in the treatment of advanced gastric cancer–laparoscopic surgery and adjuvant chemotherapy– |
Satellite
Symposium82 MEDICO'S HIRATA INC.
VIVARF Seminar |
18:00 |
| 30 |
|
|
|
|
30 |
| 45 |
|
|
|
|
|
|
|
45 |
| 50 |
|
50 |
| 19:00 |
|
19:00 |
| 30 |
|
|
|
|
Social Gathering (after the Satellite Seminar) |
|
|
|
|
|
|
|
|
|
|
30 |
| 20:00 |
|
|
20:00 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
